The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial).
Cho DK, Kim JH, Park SH, Kim JC, Kim CD, Baek MY, Kim SJ, Kim SH, Kwon TH, Kim YL, Kim YW, Chang SK.
Cho DK, et al. Among authors: kim cd, kim yl, kim sh, kim sj, kim jc, kim jh, kim yw.
Transplant Proc. 2001 Nov-Dec;33(7-8):3256-8. doi: 10.1016/s0041-1345(01)02383-1.
Transplant Proc. 2001.
PMID: 11750394
Clinical Trial.
No abstract available.